Literature DB >> 8839280

An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials.

A Parkinson1.   

Abstract

Studies of xenobiotic biotransformation by in vitro techniques are destined to play an increasingly important role in assessing the safety and efficacy of drugs and other new chemical entities. The first part of this article summarizes some of the in vitro techniques that have been developed to evaluate xenobiotics as inducers of liver microsomal cytochrome P450. The second part provides an overview of reaction phenotyping, an in vitro technology for determining which human P450 enzyme or enzymes are involved in the biotransformation of xenobiotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839280

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  15 in total

1.  From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.

Authors:  Sreenivasa C Ramaiahgari; Suramya Waidyanatha; Darlene Dixon; Michael J DeVito; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

Review 2.  Cytochrome P450 humanised mice.

Authors:  Frank J Gonzalez
Journal:  Hum Genomics       Date:  2004-05       Impact factor: 4.639

Review 3.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Authors:  Lee Jia; Xiaodong Liu
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

Review 4.  Reaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.

Authors:  Timothy W Harper; Patrick J Brassil
Journal:  AAPS J       Date:  2008-04-05       Impact factor: 4.009

Review 5.  Inhibition and induction of cytochrome P450 and the clinical implications.

Authors:  J H Lin; A Y Lu
Journal:  Clin Pharmacokinet       Date:  1998-11       Impact factor: 6.447

Review 6.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

7.  Prenatal Exposure of Cypermethrin Induces Similar Alterations in Xenobiotic-Metabolizing Cytochrome P450s and Rate-Limiting Enzymes of Neurotransmitter Synthesis in Brain Regions of Rat Offsprings During Postnatal Development.

Authors:  Anshuman Singh; Anubha Mudawal; Pratibha Maurya; Rajeev Jain; Saumya Nair; Rajendra K Shukla; Sanjay Yadav; Dhirendra Singh; Vinay Kumar Khanna; Rajnish Kumar Chaturvedi; Mohana K R Mudiam; Rao Sethumadhavan; Mohammad Imran Siddiqi; Devendra Parmar
Journal:  Mol Neurobiol       Date:  2015-06-27       Impact factor: 5.590

8.  Toxicity and Carcinogenicity of Dichlorodiphenyltrichloroethane (DDT).

Authors:  Takanori Harada; Makio Takeda; Sayuri Kojima; Naruto Tomiyama
Journal:  Toxicol Res       Date:  2016-01-31

Review 9.  Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.

Authors:  P Glue; R P Clement
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

10.  Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues.

Authors:  Katy M Olsavsky; Jeanine L Page; Mary C Johnson; Helmut Zarbl; Stephen C Strom; Curtis J Omiecinski
Journal:  Toxicol Appl Pharmacol       Date:  2007-04-21       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.